These findings connect hepatocyte and circulatory glycoprotein sialylation to the regulation of metabolism and inflammation, potentially identifying the glycome as a new target for liver-driven disease.

Modulation of hepatocyte sialylation drives spontaneous fatty liver disease and inflammation | Glycobiology | Oxford Academic